Providing it in their diet fills this need
J Neuropathol Exp Neurol 57 (4), 338342
Patients who are already managing the once-weekly injection cadence of Semaglutide or Tirzepatide and do not want to add daily injections are not good candidates for GHK-Cu, not because of any contraindication, but because they wont maintain the protocol consistently enough to see results
IV therapy is especially beneficial during cold and flu season or for anyone looking to strengthen their immune response
Dosing Protocol Both compounds use subcutaneous injection with standard insulin syringes (29 to 31 gauge)
Retatrutide is a triple hormone receptor agonist, acting on three receptors simultaneously: GLP-1 (glucagon-like peptide-1) reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) enhances insulin secretion and may improve fat metabolism Glucagon receptor increases energy expenditure and promotes fat breakdown It is worth noting that glucagon receptor agonism can, in isolation, raise blood glucose levels
